Find Academic Supervisors

Kequan Zhou is a Professor in the Department of Nutrition and Food Science at Wayne State University's College of Liberal Arts and Sciences. His research focuses on value-added nutraceuticals and functional foods for chronic disease prevention, particularly targeting Type 2 diabetes and obesity through bioactive food components. Supported by NIH, USDA, and NSF grants, Zhou leads studies on gut microbiota interactions, enzyme inhibition, and antioxidant mechanisms. Ph.D. in Food Science, University of Maryland-College Park (2005) M.S. in Public Health, China CDC (2001) M.D. in Clinical Medicine, Shandong University (1998) Zhou's recent work explores probiotic bacteria like Akkermansia muciniphila, marine-derived antimicrobials, and grape pomace compounds. His publications span food chemistry, diabetes research, and microbiome science, with methodological innovations in enzyme immobilization and metabolite characterization. Scientific Awards 2016 - Career Development Chair Award, Wayne State University 2012 - Finalist, ACS Young Scientist Award 2010 - University Research Grant Award As a Scientific Editor for the Journal of Food Science, Zhou contributes to academic leadership while teaching graduate courses in nutrition, food safety, and functional foods. His interdisciplinary approach bridges food science, pharmacology, and public health.

• Nutraceuticals
• Functional Foods
• Bioactive Food Components
• +6 more

Dr. Yoon Seok Kim is a Postdoctoral Fellow at Stanford University’s Department of Bioengineering, focusing on structural and mechanistic studies of light-gated ion channels. He earned his Ph.D. in Bioengineering at Stanford, mentored by Drs. Karl Deisseroth and Brian Kobilka, with research centered on ion channel selectivity and optogenetic applications. Education: Ph.D. in Bioengineering, Stanford University Dr. Kim’s research spans Optogenetics , Structural Biology , and Neuroscience , particularly the molecular mechanisms of ion channels in neural and glioma contexts. His work includes structural analysis of potassium-selective channelrhodopsins and synaptic mechanisms in neurodegenerative diseases. Recent publications highlight interdisciplinary trends, merging Neuroscience , Molecular Biology , and Bioengineering , with subfields like diffuse midline gliomas , dopamine neuron resilience , and machine learning in protein engineering . His studies often integrate advanced imaging and optogenetic tools.

• Optogenetics
• Structural Biology
• Neuroscience
• +3 more

Charles G Hoogstraten is an Associate Professor at the Department of Biochemistry & Molecular Biology, Michigan State University, and serves as Assistant Director for Undergraduate Education. His research focuses on RNA conformational dynamics and molecular function, utilizing advanced biophysical techniques such as NMR spectroscopy, surface plasmon resonance (SPR), and molecular dynamics simulations. Ph.D. (1995) - University of Wisconsin-Madison B.S. (1990) - Michigan State University, Chemistry & Biochemistry Previous appointments: UC Davis (1998-2002), University of Colorado, Boulder (1995-98) His work investigates the relationship between RNA structural flexibility and catalytic function, particularly in ribozymes like the hairpin ribozyme. Key contributions include developing novel isotope labeling methods and chemically constrained nucleotides to study RNA backbone dynamics and docking mechanisms. Collaborations with computational biologists enhance atomic-level understanding of these processes. Recent publications highlight his expertise in RNA tertiary structure, metal ion coordination, and spectroscopic analysis. His lab applies techniques such as SPR for docking kinetics, CD difference assays for equilibrium studies, and MD simulations to map RNA energy landscapes. Howard Hughes Medical Institute Predoctoral Fellowship Helen Hay Whitney Postdoctoral Fellowship Hoogstraten teaches advanced biochemistry courses (BMB 461, BMB 829) and leads the Hoogstraten Lab, which bridges experimental biophysics with computational modeling to unravel RNA-catalyzed reactions.

• RNA Biochemistry
• Structural Biology
• Biophysics
• +3 more

Christoph Benning is a University Distinguished Professor at Michigan State University, holding appointments in the Department of Biochemistry & Molecular Biology , Molecular Plant Sciences Program , Plant Biology , and Genetics & Genome Sciences Program . He leads the MSU-DOE Plant Research Laboratory and contributes to the Cell & Molecular Biology Program and BioMolecular Science Gateway . Ph.D., 1991, Michigan State University M.S., 1986, Albert-Ludwigs Universitaet, Freiburg, Germany Postdoctoral Researcher, 1991-1993, Michigan State University Group Leader, 1993-1997, Institut fuer Genbiologische Forschung Berlin GmbH His research centers on lipid metabolism in photosynthetic organisms , with a focus on chloroplast membrane assembly, lipid remodeling under stress, and biofuel production from algae. His lab uses Arabidopsis and Chlamydomonas to study genetic and biochemical mechanisms governing lipid biosynthesis, stress tolerance, and cellular quiescence in algae. Recent publications highlight advancements in chloroplast nanofactories , ER-chloroplast lipid transport , and WRINKLED1 transcription factor engineering to boost lipid accumulation. These works span synthetic biology , metabolic engineering , and environmental stress responses in plants and algae. Scientific Awards : Fellow of the American Society of Plant Biologists (2025), Member of the National Academy of Sciences (2025), Senior Member of the National Academy of Inventors (2022), and multiple teaching/mentoring awards. Advising : Recognized for mentoring graduate and postdoctoral researchers. Labs & Collaborations : Leads the Benning Lab at MSU, with DOE-funded projects and partnerships in algal biofuel research.

• Lipid metabolism
• Photosynthetic organisms
• Chloroplast membrane assembly
• +3 more

Alvaro Köhn-Luque is an Associate Professor at the Oslo Center for Biostatistics and Epidemiology, University of Oslo, and Group Leader at the Department of Medical Genetics, Oslo University Hospital. His work bridges mathematical modeling with clinical applications, particularly in cancer research. His academic background includes a PhD in Mathematical and Computational Biology from Complutense University of Madrid (2012), preceded by multiple Master's degrees in Mathematics and Physics from Spanish universities. Dr. Köhn-Luque's research focuses on mathematical oncology , developing computational models to understand cancer dynamics and improve treatment strategies. His work spans multiscale modeling of tumor growth, personalized cancer medicine through computer simulations, and biomarker discovery using machine learning approaches. He has made significant contributions to modeling breast cancer progression and treatment response, particularly in the context of endocrine therapy and CDK4/6 inhibition. His recent publications demonstrate a strong trend toward integrating mechanistic learning approaches that combine mathematical models with machine learning techniques. This hybrid methodology allows for more accurate prediction of treatment outcomes while maintaining biological interpretability. His work frequently involves collaboration with clinical researchers to ensure models are grounded in real patient data and have direct translational potential. Computational modeling of tumor heterogeneity and drug response Development of methods for phenotypic deconvolution in cancer cell populations Integration of multi-omics data for personalized treatment prediction Application of birth-death processes to model tumor evolution Creation of user-friendly computational tools for biomedical researchers Dr. Köhn-Luque has supervised multiple PhD students including Even M Myklebust, Salim Ghannoum, and Xiaoran Lai, and has secured funding for projects including RESCUE, BigInsight, and Integreat. His research demonstrates a consistent trajectory from theoretical mathematical biology toward increasingly clinically relevant applications in personalized cancer medicine.

• Mathematical Oncology
• Computational Biology
• Biostatistics
• +7 more

Dr. Charles Harrington is a Senior Research Fellow at the University of Aberdeen's School of Medicine, Medical Sciences and Nutrition. With a background in microbiology, he has transitioned to become a leading researcher in neurodegenerative diseases, particularly focusing on Alzheimer's disease and tau protein biology. His career spans over four decades, with significant contributions to understanding the molecular mechanisms of protein aggregation in neurodegenerative conditions. BSc (Hons) Microbiology, University of Glasgow (1977) PhD Microbiology, University of Glasgow (1980) Harrington's research interests center on the biology of tau protein in aging and Alzheimer's disease, with emphasis on diseases characterized by protein aggregation and methods to prevent these processes. His work has evolved from early studies on microbial cell walls to current investigations of tau pathology, demonstrating remarkable interdisciplinary expertise. He has developed assays for screening tau aggregation inhibitors and has extensively studied the therapeutic potential of hydromethylthionine. Analysis of his recent publications (2021-2025) reveals a strong focus on tau protein aggregation mechanisms, neuroinflammation, synaptic dysfunction in neurodegenerative diseases, and the therapeutic effects of tau aggregation inhibitors. His work frequently examines interactions between different therapeutic approaches, particularly how cholinesterase inhibitors might interfere with tau-targeting treatments. Harrington's research bridges molecular mechanisms with clinical applications, contributing significantly to the development of biomarkers and therapeutic strategies for Alzheimer's disease and related tauopathies. As Chief Scientific Officer for TauRx Therapeutics Ltd, Harrington oversees non-clinical activities for a company conducting phase 3 trials of hydromethylthionine. His collaborative work spans multiple international institutions, with numerous co-authors across neuroscience, biochemistry, and clinical research fields. While specific grant information isn't detailed in the provided text, his extensive publication record suggests substantial research funding support over his career. Harrington's laboratory work appears focused on tau transgenic mouse models, particularly investigating how tau pathology affects synaptic function, neurotransmitter systems, and behavioral outcomes. His research team has developed sophisticated methods for studying protein aggregation and its consequences in neurodegenerative disease models.

• Neurodegenerative Diseases
• Alzheimer's Disease
• Tau Protein Biology
• +3 more

Prof. Michael Vogel is a Professor at the Institute for Condensed Matter Physics at Darmstadt University of Technology (Technische Universität Darmstadt), where he leads the Molecular Dynamics in Condensed Matter research group. His work focuses on understanding the microscopic structure and dynamics of condensed matter systems and relating these to macroscopic properties. Research Interests Prof. Vogel's research spans several key areas in condensed matter physics and physical chemistry. His group investigates the structure and dynamics of condensed matter—from simple liquids and soft matter to crystalline and amorphous solids. Specific research focuses include: Water Anomalies: Exploring the fundamental understanding of water's anomalies, particularly testing the hypothesis of a transition between two liquid phases in supercooled water. Ion Transport: Studying microscopic mechanisms of ion movement in energy materials, with applications to lithium-ion batteries and fuel cells. Glass Transition: Investigating cooperative and heterogeneous motion processes during the glass transition to contribute to fundamental understanding. Protein Dynamics: Examining the interplay between protein and solvent dynamics, particularly in biological function. Ionic Liquids: Analyzing structural and dynamic heterogeneities in ionic liquids and their relationship to macroscopic properties. Liquids at Interfaces: Understanding how interfaces alter the properties of liquids, especially water, when confined in nanoscopic geometries. Research Methodology Prof. Vogel's group combines modern experimental techniques, particularly nuclear magnetic resonance (NMR) spectroscopy, with computational approaches like molecular dynamics simulations. This dual approach allows for comprehensive characterization of both local molecular motions and long-range transport properties. Their work often involves analyzing systems under confinement, at interfaces, or in supercooled states to reveal fundamental mechanisms that govern material behavior. Scientific Contributions Prof. Vogel has made significant contributions to understanding: The role of dynamic heterogeneities in glass-forming systems Mechanisms of ion transport in solid-state electrolytes The behavior of water in confined geometries and at interfaces The coupling between protein and solvent dynamics Structural and dynamic properties of ionic liquids Research Team and Facilities Prof. Vogel leads an active research group at TU Darmstadt with access to advanced NMR facilities and computational resources. His team regularly publishes in high-impact journals across physics, chemistry, and materials science. The group collaborates with other research institutions and participates in interdisciplinary projects such as the DFG Research Group 1583 on "Hydrogen-bonding liquids in the presence of internal interfaces of different hydroaffinity."

• Molecular Dynamics
• Condensed Matter Physics
• Glass Transition
• +6 more

Valerie Welborn is an Assistant Professor in the Department of Chemistry within the College of Science at Virginia Tech. Her research program focuses on multiscale simulation of condensed phase systems, particularly examining the role of electric fields in biological interfaces and biological-like systems. She leads an active research group that bridges computational chemistry with experimental validation through multiple collaborations. Dr. Welborn's research interests span protein dynamics and function, characterization of structural and functional water, polysaccharides in solution, and polymer design for metal chelation. Her work combines morphological, structural, dynamic and electronic factors to develop new models of biological interfaces, with particular emphasis on how water interacts at a fundamental molecular level with biological entities such as proteins and bone tissues. She specializes in electric field calculations to understand protein flexibility in catalysis and ion transport, seeking to reconcile protein dynamics with electrostatic preorganization theory. Her recent publications demonstrate strong activity across multiple domains, with particular emphasis on electric field analysis in protein function, water dynamics at biological interfaces, and polymer design for metal chelation. Her work shows a consistent trajectory toward increasingly complex biological systems and more sophisticated computational approaches, including polarizable force field methods and multiscale modeling techniques. Centre for Doctoral Training (CDT) on Theory and Simulation of Materials (TSM) Ph.D. Prize for Research Excellence, 2014 Outstanding Contribution to Outreach and Public Engagement, CDT TSM, 2014 Engineering and Physical Sciences Research Council (EPSRC) fully-funded Ph.D. Fellowship, CDT TSM, 2011 Editor-selected as '2021 Hot PCCP article' Front cover article in Phys. Chem. Chem. Phys. Dr. Welborn actively mentors a diverse group of researchers, including multiple postdoctoral associates, graduate students across chemistry and related disciplines, and undergraduate researchers. Her lab participates in the NSF Materials Innovation Platform GlycoMIP (DMR-1933525), focusing on polysaccharide research. She collaborates extensively with experimental groups, particularly with Professor Michael Schulz on polymer design for metal chelation projects. Her lab develops computational tools like the ELECTRIC software package for electric field calculations in biomolecular systems. The Welborn group maintains active research programs in four main areas: protein dynamics and function, characterization of structural and functional water, polymer design for metal chelation, and polysaccharides in solution. Each program employs specialized computational approaches to address fundamental questions in biological chemistry, with particular emphasis on how electric fields govern molecular behavior at biological interfaces.

• Computational Chemistry
• Biophysical Chemistry
• Molecular Dynamics Simulations
• +7 more

Dr. Shahaf Peleg is the Head of the Energy Metabolism and Epigenetics Working Group at the Research Institute for Farm Animal Biology (FBN). His research focuses on aging biology, epigenetic mechanisms, and metabolic interventions. Key areas include histone acetylation regulation, mitochondrial function, and dietary effects on longevity. He uses models like Drosophila, C. elegans, and mice (e.g., Titan mouse) to study aging pathways. Leading interdisciplinary projects on energy metabolism and epigenetic interactions. Developing optogenetic tools for mitochondrial research. Expertise in lipidomics and circadian metabolism. Recent work emphasizes dietary interventions in obesity-related aging and optogenetic rejuvenation of cellular energetics. Active in collaborative networks like ARDD Emerging Science workshops. Publications span metabolic pathway analysis, alcohol's epigenetic impacts, and longevity biomarkers. His team's Titan mouse model is a key tool for testing frailty attenuation strategies.

• Aging Biology
• Epigenetics
• Metabolic Regulation
• +7 more

Prof. Mike Boxem is a Professor in the Department of Biology at Utrecht University's Faculty of Science, specializing in Developmental Biology. His research focuses on epithelial polarity, cell polarity complexes, and C. elegans genetics. He holds a PhD from Utrecht University (2002) and completed postdoctoral work at the Dana-Farber Cancer Institute. Notable honors include the NWO Vici (2016), NWO Vidi (2010), and ECHO grants. He leads the PolarNet Marie Curie ITN network and has supervised 8 research projects. His work contributes to understanding cell polarity mechanisms and developmental processes in C. elegans. Educations: BSc Medical Biology, VU University Amsterdam PhD in Biology, Utrecht University (2002) Research Interests: Boxem’s lab investigates how cell polarity complexes regulate epithelial tissue organization in C. elegans. Key topics include Crumbs polarity proteins, intermediate filaments, and signaling pathways controlling lumen formation and germline development. His work integrates genetic, biochemical, and imaging approaches to dissect molecular mechanisms underlying polarity establishment and maintenance. Grants & Awards: NWO Vici Grant (2016) - Supports long-term research NWO Vidi Grant (2010) - Established his independent lab ECHO Grant (2014) - European funding for collaborative projects Labs/Teams: His group is part of the Biodynamics and Biocomplexity research division. Collaborations span global networks, including the PolarNet consortium focusing on epithelial polarity.

• Developmental Biology
• Cell Polarity
• Protein-Protein Interactions
• +3 more

Professor Neil Harrison is a Clinical Professor in Neuroimaging at Cardiff University's School of Medicine, leading the Immunopsychiatry Research Group at CUBRIC and the Haydn Ellis Building. He previously established the UK's first Clinical Immunopsychiatry Service in Sussex. His expertise spans neuroimaging, psychiatry, and immunology, focusing on how immune systems interact with brain function in mental illnesses like depression and Alzheimer’s. He holds grants from the MRC, Wellcome Trust, and Janssen Pharmaceutics. Education: PhD in Neuroscience from UCL’s Wellcome Trust Centre for Neuroimaging, psychiatry training at the Maudsley Hospital and National Hospital for Neurology, Queen Square. Research interests include neuroinflammation’s role in mental health, with a focus on translational approaches like wearable technology for early disease detection. He chairs the Psychoneuroimmunology Research Society and advises the Wellcome Trust’s Clinical Interview Committee. Grants and collaborations include work on imaging brain inflammation, chronic fatigue mechanisms, and translational immunopsychiatry. His lab investigates neuroimaging biomarkers and clinical applications of immunological insights in mental health.

• Immunopsychiatry
• Neuroimaging
• Psychiatry
• +5 more

Jie Peng, Ph.D., is a Professor and Vice-Chair for Graduate Affairs in the Department of Statistics at the University of California, Davis. Her research focuses on statistical methodologies with applications in genomics, neuroimaging, and functional data analysis. She holds a Ph.D. from Stanford University and is actively involved in advancing statistical theory and its practical implementations in biomedical and computational sciences. Education Ph.D. in Statistics, Stanford University Research Interests Dr. Peng’s work spans several key areas including graphical models, high-dimensional inference, and neuroimaging analysis. She develops innovative statistical tools for analyzing complex biological data, such as tumor genomics and brain connectivity patterns derived from diffusion MRI. Her research emphasizes the interplay between theoretical statistics and real-world applications in healthcare and precision medicine. Professional Contributions She serves as an Associate Editor for the Journal of Computational and Graphical Statistics and has contributed to numerous high-impact publications. Her methods have been applied to identify biomarkers in ovarian cancer and to study brain lateralization using Human Connectome Project (HCP) data. Dr. Peng also leads efforts in developing computational frameworks for spatial transcriptomics and dynamic network modeling.

• Graphical Models
• High Dimensional Inference
• Functional Data Analysis
• +4 more

Yong Zeng is an Associate Professor in the Department of Chemistry at the University of Florida. He leads the Zeng Group, focusing on precision medicine through innovative micro/nanoscale technologies. His research bridges chemistry, materials science, bioengineering, and medicine to develop tools for non-invasive cancer and Alzheimer’s disease diagnosis. Key projects include lab-on-a-chip systems, exosome-based liquid biopsy platforms, and CRISPR-driven diagnostic assays. Education: Ph.D., Chemistry, University of Alberta (2007) Postdoctoral Research, University of California, Berkeley (2008-2012) Research Interests: Dr. Zeng’s work centers on creating transformative technologies for precision diagnostics, including nano-engineered microfluidic devices, smart bioanalyzers with AI integration, and exosome-based biomarker analysis. His group has pioneered methods for detecting extracellular vesicles, proteins, nucleic acids, and glycans in blood samples. Awards: 2013 Bioanalysis Young Investigator Award Grants & Collaborations: Supported by NIH grants, his lab collaborates with clinicians and biologists to translate technologies into clinical tools. Notable collaborations include exosome research for precision immunotherapy and liquid biopsy-based cancer diagnosis. Labs/Teams: The Zeng Group operates at the interface of engineering and medicine, emphasizing translational research to bridge laboratory innovations with clinical applications.

• Precision Medicine
• Nanotechnology
• Biomarker Development
• +6 more

Mark Smeltzer is a Professor in the Department of Microbiology and Immunology and Department of Orthopaedics at the University of Arkansas for Medical Sciences (UAMS). He specializes in the molecular pathogenesis of Staphylococcus aureus infections, particularly focusing on its role in orthopaedic infections, biofilm formation, and antibiotic resistance mechanisms. His work integrates molecular biology, proteomics, and nanotechnology to develop novel therapeutic strategies. Dr. Smeltzer earned his Ph.D. from Kansas State University and completed postdoctoral training under Dr. John J. Iandolo. His research is supported by grants from the National Institute of Allergy and Infectious Diseases (NIAID), the Congressionally-Directed Medical Research Program, and the Texas Hip and Knee Foundation. Key collaborations include projects with Dr. Jingyi Chen (nanotherapeutics) and Dr. Alexandru Biris (bone regeneration scaffolds). Research Interests: Mechanisms of S. aureus biofilm formation and antibiotic resistance Role of the sarA regulatory gene in virulence and infection Development of nanoparticle-based therapies for biofilm-associated infections Orthopaedic device-related infections and bone regeneration Key Findings: Identified sarA mutations limiting biofilm formation and enhancing antibiotic susceptibility Developed gold nanocage-based systems for targeted antibiotic delivery and photothermal therapy Discovered protease-dependent virulence factors critical for infection progression Funding Highlights: NIAID grants for sarA regulatory pathway studies Congressionally-Directed Medical Research Program grants for small molecule inhibitors Collaborative grants for nanotherapeutic and bone regeneration projects Dr. Smeltzer’s lab actively explores translational approaches to combat antibiotic-resistant infections, with a focus on clinical applications in orthopaedics and infectious diseases.

• Bacterial Pathogenesis
• Antimicrobial Resistance
• Infectious Disease
• +4 more

Ellen Rothenberg is the Edward B. Lewis Professor of Biology at the California Institute of Technology (Caltech). She earned her A.B. in Biochemical Sciences from Harvard University (1972) and a Ph.D. in Molecular Biology from MIT (1977). Her academic career at Caltech spans roles from Assistant Professor (1982–88) to her current position. She holds the Ruddock Professorship (2007–21), Distinguished Professor (2021–), and Lewis Professor (2021–). Her research focuses on transcriptional networks governing T-cell development and signaling, particularly how hematopoietic stem cells commit to T-lymphocyte lineages. Using in vitro systems, molecular genetics, and genomic approaches, her lab explores transcription factor interactions, chromatin dynamics, and signaling pathways that drive T-cell identity. Key interests include understanding stem-cell multipotentiality loss, irreversible commitment mechanisms, and links to autoimmune predisposition. Rothenberg is an Andrew D. White Professor-at-Large at Cornell University (2021–2027), collaborating with immunology and molecular biology departments. She has organized international conferences, served on NIH review panels, and advises biotech firms like Century Therapeutics. Her honors include membership in the National Academy of Sciences, AAAS and American Academy of Arts and Sciences fellowships, and the Feynman Teaching Prize (2016). Education: A.B., Harvard University, Biochemical Sciences, 1972 Ph.D., Massachusetts Institute of Technology, Molecular Biology, 1977 Awards: AAAS Fellow, American Academy of Arts and Sciences Fellow Member, National Academy of Sciences American Association of Immunologists Distinguished Fellow Richard P. Feynman Prize for Excellence in Teaching (2016) External Roles: Cornell’s ADW-PAL (2021–2027), collaborating with faculty hosts Brian Rudd and Andrew Grimson Scientific Advisor, Century Therapeutics, A2 Biotherapeutics, Kite Pharma Her work bridges basic research and clinical applications, including immunogenomics symposia and public lectures on T-cell programming. Ongoing projects explore evolutionary origins of lymphocyte development through comparative analysis of basal vertebrates.

• Cellular and Developmental Biology
• Molecular Biology
• Immunology
• +3 more